Results 41 to 50 of about 895 (176)

Role of temporary portosystemic surgical shunt during liver resection to prevent a post-resection small for size-like syndrome [PDF]

open access: yes
Liver resection stands as the gold-standard therapeutic approach for selected cases of hepatocellular carcinoma (HCC). The extent of resectable parenchyma hinges upon the underlying liver function and its regenerative potential.
Cillo, Umberto   +2 more
core   +1 more source

Treatment Approach in Patients with Decompensated Liver Cirrhosis [PDF]

open access: yes, 2021
Chronic liver disease and decompensated cirrhosis are the major causes of morbidity and mortality in the world. According to current data, deaths due to liver cirrhosis constitute 2.4% of the total deaths worldwide.
Delik, Anıl, Ülger, Yakup
core   +2 more sources

Advances in Factors and Risk Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt

open access: yesPortal Hypertension & Cirrhosis
Hepatic encephalopathy (HE) is a frequent complication that occurs following transjugular intrahepatic portosystemic shunt (TIPS) procedures and has a considerable effect on patient prognosis.
Lixin Song, Xinyi Qiao, Yu Sun, Hui Yang
doaj   +1 more source

Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis [PDF]

open access: yes, 2018
BACKGROUND: Hepatosplenic schistosomiasis is an important cause of variceal bleeding in low-income countries. Randomised clinical trials have evaluated the outcomes of two categories of surgical interventions, shunts and devascularisation procedures ...
Brand, Martin   +2 more
core   +1 more source

Budd-Chiari syndrome-acute-on-chronic liver failure with simultaneous thrombotic and non-thrombotic acute insults

open access: yesInternational Journal of Gastrointestinal Intervention
A 21-year-old man presented with acute onset of jaundice, abdominal pain, ascites, and hepatomegaly, along with a history of Budd-Chiari syndrome previously treated with vena cava angioplasty.
Vinay Borkar   +9 more
doaj   +1 more source

Stentul metalic autoexpandabil– O nouă metodă de hemostază a varicelor esofagiene hemoragice [PDF]

open access: yes, 2021
Varicele esofagiene complicate cu hemoragie reprezintă o afecţiune potenţial fatală a hipertensiunii portale. Hemoragia variceală acută este asociată cu o mortalitate de 30–50%.
Bunic, Gheorghe   +3 more
core   +1 more source

Prosthetic H-Graft Portacaval Shunts vs Transjugular Intrahepatic Portasystemic Stent Shunts: 18-Year Follow-Up of a Randomized Trial

open access: yesJournal of the American College of Surgeons, 2012
Widespread application of transjugular intrahepatic portasystemic shunt (TIPS) continues despite the lack of trials documenting efficacy superior to surgical shunting. Here we present an 18-year follow-up of a prospective randomized trial comparing TIPS with small-diameter prosthetic H-graft portacaval shunt (HGPCS) for portal decompression.Beginning ...
Alexander S, Rosemurgy   +4 more
openaire   +3 more sources

Liver surgery in cirrhosis and portal hypertension [PDF]

open access: yes, 2016
The prevalence of hepatic cirrhosis in Europe and the United States, currently 250 patients per 100000 inhabitants, is steadily increasing. Thus, we observe a significant increase in patients with cirrhosis and portal hypertension needing liver ...
Hackl, Christina   +3 more
core   +1 more source

A Prospective Trial of Transjugular Intrahepatic Portasystemic Stent Shunts Versus Small-Diameter Prosthetic H-Graft Portacaval Shunts in the Treatment of Bleeding Varices

open access: yesAnnals of Surgery, 1996
The authors compare transjugular intrahepatic portasystemic stent shunts (TIPS) to small-diameter prosthetic H-graft portacaval shunts (HGPCS).Transjugular intrahepatic portasystemic stent shunts have been embraced as a first-line therapy in the treatment of bleeding varices due to portal hypertension, although they have not been compared to ...
A S, Rosemurgy   +4 more
openaire   +3 more sources

Cardiovascular dysfunction in patients with liver cirrhosis [PDF]

open access: yes, 2020
Hyperdynamic syndrome is a well-known clinical condition found in patients with cirrhosis and portal hypertension, characterized by increased heart rate and cardiac output, and reduced systemic vascular resistance and arterial blood pressure.
Francesco Purrello   +4 more
core  

Home - About - Disclaimer - Privacy